tiprankstipranks
Advertisement
Advertisement

Guardian Pharmacy Services Ends Controlled Company Status on NYSE

Story Highlights
  • Guardian Pharmacy Services arranged private repurchases of up to 1.83 million shares, funded by future underwritten offerings, with participating holders agreeing to a post-closing lock-up.
  • The March 20, 2026 offering enabled a non-dilutive share cancellation and ended controlled-company status, pushing Guardian onto full NYSE governance compliance with a new independent committee.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Guardian Pharmacy Services Ends Controlled Company Status on NYSE

Claim 55% Off TipRanks

Guardian Pharmacy Services, Inc. Class A ( (GRDN) ) has provided an announcement.

On March 18, 2026, Guardian Pharmacy Services entered into stock purchase agreements with certain Class A shareholders, enabling the company to repurchase up to 1,833,344 shares in private transactions at prices tied to future underwritten offerings, while those holders agreed to a lock-up extending at least until June 30, 2026. On March 20, 2026, the company completed an underwritten offering of 6.9 million Class A shares, used its proceeds from 1.02 million newly issued shares to buy and cancel an equal number of outstanding shares with no net change in shares outstanding, and, as selling stockholders lost majority voting control, Guardian ceased to qualify as a NYSE “controlled company” and promptly formed an independent Nominating and Governance Committee to comply with full exchange governance requirements.

The most recent analyst rating on (GRDN) stock is a Hold with a $37.00 price target. To see the full list of analyst forecasts on Guardian Pharmacy Services, Inc. Class A stock, see the GRDN Stock Forecast page.

Spark’s Take on GRDN Stock

According to Spark, TipRanks’ AI Analyst, GRDN is a Neutral.

The score is driven primarily by improving fundamentals (strong cash generation and a significantly strengthened balance sheet) and supportive technical momentum. This is tempered by a high P/E valuation and policy/operational headwinds highlighted on the earnings call (IRA impacts and some nonrecurring recent benefits).

To see Spark’s full report on GRDN stock, click here.

More about Guardian Pharmacy Services, Inc. Class A

Guardian Pharmacy Services, Inc. operates in the pharmacy services industry, providing medication management and related pharmacy solutions, with its equity traded on the New York Stock Exchange. The company’s capital structure includes Class A common stock held by public investors and former Class B shares converted in connection with a 2024 corporate reorganization, and it is now subject to standard NYSE corporate governance rules following the loss of controlled company status.

Average Trading Volume: 308,605

Technical Sentiment Signal: Buy

Current Market Cap: $2.26B

For an in-depth examination of GRDN stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1